Group One Trading’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-593
| Closed | -$2K | – | 2304 |
|
|
2017
Q4 | $2K | Sell |
593
-7
| -1% | -$24 | ﹤0.01% | 1300 |
|
|
2017
Q3 | $2K | Buy |
+600
| New | +$2K | ﹤0.01% | 1234 |
|
|
2017
Q2 | – | Sell |
-131
| Closed | -$1K | – | 2185 |
|
|
2017
Q1 | $1K | Sell |
131
-2,754
| -95% | -$21K | ﹤0.01% | 1231 |
|
|
2016
Q4 | $12K | Sell |
2,885
-3,137
| -52% | -$13K | ﹤0.01% | 1071 |
|
|
2016
Q3 | $59K | Buy |
+6,022
| New | +$59K | ﹤0.01% | 747 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 2060 |
|
|
2016
Q1 | – | Sell |
-1,369
| Closed | -$18K | – | 2071 |
|
|
2015
Q4 | $18K | Sell |
1,369
-5,039
| -79% | -$66.3K | ﹤0.01% | 1078 |
|
|
2015
Q3 | $105K | Sell |
6,408
-13,157
| -67% | -$216K | ﹤0.01% | 748 |
|
|
2015
Q2 | $439K | Buy |
19,565
+16,501
| +539% | +$370K | 0.01% | 419 |
|
|
2015
Q1 | $30K | Sell |
3,064
-5,794
| -65% | -$56.7K | ﹤0.01% | 932 |
|
|
2014
Q4 | $101K | Sell |
8,858
-5,057
| -36% | -$57.7K | ﹤0.01% | 699 |
|
|
2014
Q3 | $160K | Buy |
13,915
+6,055
| +77% | +$69.6K | ﹤0.01% | 600 |
|
|
2014
Q2 | $153K | Buy |
7,860
+4,182
| +114% | +$81.4K | ﹤0.01% | 603 |
|
|
2014
Q1 | $66K | Sell |
3,678
-28,599
| -89% | -$513K | ﹤0.01% | 846 |
|
|
2013
Q4 | $341K | Buy |
32,277
+7,559
| +31% | +$79.9K | 0.01% | 436 |
|
|
2013
Q3 | $306K | Sell |
24,718
-1,256
| -5% | -$15.5K | 0.01% | 414 |
|
|
2013
Q2 | $243K | Buy |
+25,974
| New | +$243K | 0.01% | 442 |
|